A robust type I IFN response in severe COVID-19 patients has been described, which could exacerbate hyperinflammation through diverse mechanisms [67,68], but the induction of IFNE specifically and the radical differences depending on sex were unknown. This evidence concerns the gene IFNE and COVID-19.